Olvidé mi contraseña
Asóciese a SIIC en Internet para utilizar sin límites tanto siicsalud como la totalidad de los servicios bibliográficos de la institución.
Lectura recomendada:
The Cost of Diagnosing Type 2 Diabetes Mellitus By Clinical Opportunistic Screening in General Practice
Diabetic Medicine, 29(7):863-868
Lectura recomendada:
Effect of Screening for Type 2 Diabetes on Population-Level Self Rated Health Otucomes and Measures of Cardiovascullar Risk: 13-Year Follow Up of the Ely Cohort
Diabetic Medicine, 29(7):886-892
Lectura recomendada:
Haemoglobin A1c Cut-Off Point to Identify a High Risk Group of Future Diabetes: Results from the Omiya MA Cohort Study
Diabetic Medicine, 29(7):905-910
Lectura recomendada:
Improvements in Diabetes Processes of Care and Intermediate Outcomes: United States, 1988-2002
Annals of Internal Medicine, 144(7):465-474
Lectura recomendada:
Association of Glycaemia with Macrovascular and Microvascular Complications of Type 2 Diabetes (UKPDS 35): Prospective Observational Study
BMJ, 321(7258):405-412
Lectura recomendada:
Twelve- and 52-Week Efficacy of the Dipeptidyl Peptidase IV Inhibitor LAF237 in Metformin-Treated Patients with Type 2 Diabetes
Diabetes Care, 27(12):2874-2880
Lectura recomendada:
Effects of Vildagliptin on Glucose Control Over 24 Weeks in Patients with Type 2 Diabetes Inadequately Controlled with Metformin
Diabetes Care, 30(4):890-895
Lectura recomendada:
Fifty-two-Week Efficacy and Safety of Vildagliptin vs. Glimepiride in Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Metformin Monotherapy
Diabetes, Obesity and Metabolism, 11(2):157-166
Lectura recomendada:
Glycemic Control with Diet, Sulfonylurea, Metformin, or Insulin in Patients with Type 2 Diabetes Mellitus: Progressive Requirement for Multiple Therapies (UKPDS 49)
JAMA, 281(21):2005-2012
Lectura recomendada:
Efficacy and Tolerability of Vildagliptin vs. Pioglitazone when Added to Metformin: A 24-Week, Randomized, Double-Blind Study
Diabetes, Obesity and Metabolism, 10(1):82-90
Lectura recomendada:
Maternal Body Mass Index Is a Predictor of Neonatal Hypoglycemia in Gestational Diabetes Mellitus
Journal of Clinical Endocrinology and Metabolism, 97(5):1623-1628
Lectura recomendada:
Efficacy and Tolerability of Vildagliptin as Add-on Therapy to Metformin in Chinese Patients with Type 2 Diabetes Mellitus
Diabetes, Obesity and Metabolism, 14(8):737-744
Señale cuál de las siguientes opciones es común a la terapia con sitagliptina y pioglitazona:
Introducción:
La diabetes mellitus tipo 2 es una enfermedad crónica progresiva que no se logra controlar en forma adecuada a largo plazo sólo con monoterapia. La mayoría de los pacientes requerirá, con el tiempo, una segunda medicación, al no poder alcanzar las metas glucémicas recomendadas.
Lectura recomendada:
Efficacy and Safety of Initial Combination Therapy with Sitagliptin and Pioglitazone in Patients with Type 2 Diabetes: A 54-Week Study
Diabetes, Obesity and Metabolism, 14(8):745-752
Lectura recomendada:
Glycaemic Efficacy of Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors as Add-on Therapy to Metformin in Subjects With Type 2 Diabetes - A Review and Meta Analysis
Diabetes, Obesity and Metabolism, 14(8):762-767
Lectura recomendada:
Effect of Exposure to Non-Esterified Fatty Acid on Progressive Deterioration of Insulin Secretion in Patients with Type 2 Diabetes: A Long-Term Follow Up Study
Diabetic Medicine, 29(8):980-985
Lectura recomendada:
Blood Glucose Testing and Primary Prevention of Type 2 Diabetes-Evaluation of the Effect of Evidence-Based Patient Information: A Randomized Controlled Trial
Diabetic Medicine, 29(8):1011-1020